SPONSORED CONTENT
The purpose of the 340B drug pricing program remains a contested question between 340B providers and some in the pharmaceutical industry. In addition, there are questions regarding 340B’s scope including the contract pharmacy program and the definition of patient.
…
SPONSORED CONTENT
TIP: Use quarterly eRx data analysis to identify contract pharmacy expansion opportunities, including independent pharmacies.
Every quarter,
SPONSORED CONTENT
It’s easy to remember the days before 340B ESP, when setting up of a wholesale account was an easy and streamlined process. The Health Industry Number (HIN) was not something that was discussed very often prior to the manufacturer restrictions. The HIN is
…SPONSORED CONTENT
Stay ahead of the latest developments shaping the 340B landscape with Ted Slafsky, Publisher and CEO of 340B Report. In this special, hour-long insider briefing, Ted will share timely insights, important context, and practical takeaways on the policy shifts and
…SPONSORED CONTENT
As the 2025 political season heats up, federally qualified health centers (FQHCs), hospitals, STD clinics, Ryan White grantees, and other covered entities must brace for another round of uncertainty. With renewed debates around entitlement
… SPONSORED CONTENT
TIP: Entities using third-party administrators (TPAs) should understand system functionality and strengthen oversight with regular audits to reduce compliance risks.
SPONSORED CONTENT
The term “specialty medication” is often associated with a hefty price tag and numerous challenges related to claims processing. While this may be true in certain circumstances, organizations providing or considering offering specialty medications can still successfully navigate these complexities with
… SPONSORED CONTENT
TIP: Don’t Leave Compliance to Chance – Audit 100% of Your 340B Transactions.
With sweeping changes proposed
SPONSORED CONTENT
TIP: Prioritize referral consistency over volume.
When it comes to 340B referral capture, it’s tempting to focus
SPONSORED CONTENT
Please join on us April 22nd at 1:00 p.m. EST for the third installment of RxParadigm’s 340B Clearinghouse Webinar Series.
… *Sign up for news summaries and alerts from 340B Report
